Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure

AIMS: Large‐scale clinical trials have demonstrated clinical benefits of sacubitril–valsartan in symptomatic heart failure with reduced ejection fraction patients (PARADIGM‐HF), with potential benefits in patients hospitalized for acute decompensated heart failure (ADHF) (PIONEER‐HF) and fewer benef...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Carballo, David, Stirnemann, Jérôme, Garin, Nicolas, Marti, Chistophe, Serratrice, Jacques, Carballo, Sebastian
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7261587/
https://ncbi.nlm.nih.gov/pubmed/32167679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12676
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars